{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:22:11Z","timestamp":1791519731321,"version":"4.3.4"},"reference-count":126,"publisher":"Elsevier BV","issue":"29-30","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.vaccine.2008.04.054","type":"journal-article","created":{"date-parts":[[2008,5,10]],"date-time":"2008-05-10T05:26:31Z","timestamp":1210397191000},"page":"3551-3555","source":"Crossref","is-referenced-by-count":290,"title":["Sexual dimorphism of humoral immunity with human vaccines"],"prefix":"10.1016","volume":"26","author":[{"given":"Ian Francis","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.04.054_bib1","unstructured":"World Health Organization. The World Health Report 2003: shaping the future. Geneva, Switzerland: World Health Organization; 2003."},{"key":"10.1016\/j.vaccine.2008.04.054_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the asymptote? Evolution and revolution in immunology","volume":"56","author":"Janeway","year":"1989","journal-title":"Cold Spring Harbor Symp Quant Biol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib4","unstructured":"Whitacre CC, Reingold SC, O\u2019Looney PA, Blankenhorn E, Brinley F, Collier E, et al. A gender gap in autoimmunity: sex differences in autoimmune disease: focus on Multiple Sclerosis. www.sciencemag.or\/feature\/data\/983519.shl."},{"key":"10.1016\/j.vaccine.2008.04.054_bib5","series-title":"Sexual dimorphism and the immune system in principles of gender-specific medicine","first-page":"1071","author":"Rider","year":"2004"},{"key":"10.1016\/j.vaccine.2008.04.054_bib6","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1152\/jappl.2001.91.5.2366","article-title":"Genome and hormones: gender difference in physiology\u2014invited review: sex ratio and rheumatic disease","volume":"91","author":"Lockshin","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib7","doi-asserted-by":"crossref","unstructured":"WHO\u2013UNAIDS Expert Group. Gender, age and ethnicity in HIV vaccine-related research and clinical trials: report from a WHO\u2013UNAIDS consultation, 26\u201328 August 2004, Lausanne, Switzerland. AIDS 2005; 19. p. W7\u2013W28.","DOI":"10.1097\/01.aids.0000189853.29064.a8"},{"key":"10.1016\/j.vaccine.2008.04.054_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00006454-200101000-00013","article-title":"Immunologic correlates of protection induced by vaccination","volume":"20","author":"Plotkin","year":"2001","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.04.054_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0764-4469(00)87191-7","article-title":"Vaccination against major infectious diseases","volume":"323","author":"Plotkin","year":"1999","journal-title":"C R Acad Sci III-Vie"},{"key":"10.1016\/j.vaccine.2008.04.054_bib10","doi-asserted-by":"crossref","first-page":"12182","DOI":"10.1128\/JVI.75.24.12182-12187.2001","article-title":"Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals","volume":"75","author":"Goronzy","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib11","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1016\/j.vaccine.2007.08.042","article-title":"Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects","volume":"25","author":"Couch","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib12","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1016\/j.vaccine.2006.04.032","article-title":"Immune response to influenza vaccination in community-dwelling Chinese elderly persons","volume":"24","author":"Hui","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib13","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.vaccine.2005.11.057","article-title":"Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults","volume":"24","author":"Cook","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib14","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1016\/j.vaccine.2007.07.015","article-title":"Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2004\u20132005 influenza periods","volume":"25","author":"Vila-Corcoles","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib15","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/S0264-410X(02)00181-0","article-title":"Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community","volume":"20","author":"Wang","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1017\/S095026880005874X","article-title":"Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989\u201390 using a general practice database","volume":"115","author":"Fleming","year":"1995","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.04.054_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1532-5415.1999.tb04574.x","article-title":"Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic","volume":"47","author":"Ohmit","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2008.04.054_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbi.2006.04.158","article-title":"Eccentric exercise as an adjuvant to influenza vaccination in humans","volume":"21","author":"Edwards","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2008.04.054_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbi.2005.07.001","article-title":"Acute stress exposure prior to influenza vaccination enhances antibody response in women","volume":"20","author":"Edwards","year":"2006","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2008.04.054_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbi.2004.10.004","article-title":"The association between life events, social support and antibody status following thymus-dependent and thymus-independent vaccinations in healthy young adults","volume":"19","author":"Phillips","year":"2005","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2008.04.054_bib21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.vaccine.2006.10.024","article-title":"Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults","volume":"25","author":"Hohler","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib22","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1016\/j.vaccine.2006.04.016","article-title":"Hepatitis A\/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors","volume":"24","author":"Van Der Wielen","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2893.1998.00101.x","article-title":"Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitisA\/hepatitis B vaccination in 242 adult volunteers","volume":"5","author":"Reutter","year":"1998","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib24","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/S0264-410X(03)00399-2","article-title":"Immunogencity of combined hepatitis A and B vaccine in elderly persons","volume":"21","author":"Wolters","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1386-6346(97)00079-X","article-title":"Antibody response to inactivated hepatitis A vaccine","volume":"9","author":"Tanaka","year":"1997","journal-title":"Hepatol Res"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.04.054_bib26","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/0264-410X(92)90561-W","article-title":"Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine","volume":"10","author":"Goubau","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0168-8278(97)80039-6","article-title":"Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults","volume":"26","author":"Chen","year":"1995","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.04.054_bib28","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/infdis\/171.Supplement_1.S50","article-title":"Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals","volume":"171","author":"Sandman","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0264-410X(93)90128-K","article-title":"Simultaneous active and passive immunization against hepatitis A studied in a population of travellers","volume":"11","author":"Wagner","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.510270336","article-title":"Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease","volume":"27","author":"Keeffe","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2008.04.054_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/infdis\/171.3.676","article-title":"Immunogenicity of an inactivated hepatitis A vaccine in Alaska native children and native and non-native adults","volume":"171","author":"McMahon","year":"1995","journal-title":"J Infect D"},{"key":"10.1016\/j.vaccine.2008.04.054_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1708-8305.2006.00001.x","article-title":"Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal\u00ae) in the elderly","volume":"13","author":"D\u2019Acremont","year":"2006","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2008.04.054_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2893.2005.00658.x","article-title":"Response to hepatitis A vaccine in HIV-positive patients","volume":"13","author":"Weissman","year":"2006","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib34","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/bmj.304.6837.1272","article-title":"Clinical trial with inactivated hepatitis A vaccine and recommendations for its use","volume":"304","author":"Tilzey","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2008.04.054_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jmv.10244","article-title":"Long-term immunogenicity of an inactivated virosomal hepatitis A vaccine","volume":"68","author":"Bovier","year":"2002","journal-title":"J Med Viol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib36","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1016\/S0264-410X(03)00502-4","article-title":"Hepatitis A vaccine failure: how to treat the threat","volume":"21","author":"Taliani","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib37","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(02)08764-0","article-title":"Hepatitis A vaccine failure","volume":"359","author":"Elliott","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.054_bib38","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1055\/s-2002-32940","article-title":"Acute hepatitis A despite regular vaccination against hepatitis A and B","volume":"127","author":"Junge","year":"2002","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.vaccine.2008.04.054_bib39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1017\/S0950268800047506","article-title":"Immunization against hepatitis B\u2014what can we expect. Results of a survey of antibody response to immunization in person \u2018at risk\u2019 of occupational exposure to hepatitis B","volume":"140","author":"Westmoreland","year":"1990","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.04.054_bib40","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0264-410X(00)00410-2","article-title":"Antibody\u2014response to three recombinant hepatitis B vaccines: comparative evaluation of multicentre travel-clinic based experience","volume":"19","author":"Rendi-Wagner","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib41","first-page":"CR516","article-title":"Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes","volume":"8","author":"Halota","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.vaccine.2008.04.054_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2337\/diacare.20.2.148","article-title":"Hepatitis B vaccination in diabetic patients","volume":"20","author":"Douvin","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vaccine.2008.04.054_bib43","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1001\/jama.270.24.2931","article-title":"Hepatitis B vaccine responsiveness in Connecticut Public Safety Personnel","volume":"270","author":"Roome","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.04.054_bib44","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3748\/wjg.v9.i5.1132","article-title":"Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders","volume":"9","author":"Das","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib45","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/archinte.156.19.2226","article-title":"Immunogenicity of a recombinant hepatitis B vaccine in adults","volume":"156","author":"Bock","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2008.04.054_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S0950268800030740","article-title":"Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age","volume":"103","author":"Morris","year":"1989","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.04.054_bib47","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(84)92740-5","article-title":"Clinical evaluation of a recombinant hepatitis B vaccine","volume":"2","author":"Jilg","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.054_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF01962073","article-title":"Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination","volume":"11","author":"Hess","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/00365549209052627","article-title":"Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response","volume":"24","author":"Struve","year":"1992","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib50","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1478-3231.2005.01157.x","article-title":"Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan)","volume":"25","author":"Yen","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.vaccine.2008.04.054_bib51","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/BF00145379","article-title":"Long-term immunogenicity, safety and efficacy of a recombinant hepatitis B vaccine in healthy adults","volume":"8","author":"Dentico","year":"1992","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib52","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1177\/00220345940730050301","article-title":"Factors associated with hepatitis B vaccine response among dentists","volume":"73","author":"Cleveland","year":"1994","journal-title":"J Dent Res"},{"key":"10.1016\/j.vaccine.2008.04.054_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1086\/502012","article-title":"Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine","volume":"23","author":"Playford","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib54","first-page":"187","article-title":"Should hepatitis B surface antibody be determined after standard vaccination?","volume":"20","author":"Wun","year":"1998","journal-title":"Hong Kong Practitioner"},{"key":"10.1016\/j.vaccine.2008.04.054_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biologicals.2006.06.001","article-title":"Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults","volume":"35","author":"Estevez","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2008.04.054_bib56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0264-410X(95)00148-T","article-title":"Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity","volume":"14","author":"Chiaramonte","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","article-title":"Immunogenicity of hepatitis B vaccines\u2014implications for persons at occupational risk of hepatitis B virus infection","volume":"15","author":"Averhoff","year":"1998","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2008.04.054_bib58","first-page":"CR762","article-title":"Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students","volume":"8","author":"Jablkowski","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.vaccine.2008.04.054_bib59","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.3748\/wjg.v11.i45.7165","article-title":"Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India","volume":"11","author":"Hussain","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0264-410X(91)90287-G","article-title":"Intradermal hepatitis B vaccination in a large hospital employee population","volume":"9","author":"Coleman","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib61","first-page":"2","article-title":"The comparison of different recombinant hepatitis B vaccines","volume":"2","author":"Cavuslu","year":"2003","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib62","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1001\/jama.270.24.2935","article-title":"Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers","volume":"270","author":"Wood","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.04.054_bib63","first-page":"5","article-title":"Immunogenicity of recombinant hepatitis B vaccine in health care workers of Boo-Ali hospital in Tehran, Iran 2002\u20132004","volume":"1","author":"Taghavi","year":"2006","journal-title":"Iran J Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib64","first-page":"63","article-title":"The immunologic response to anti-hepatitis B vaccination among medical students of Guilan University of Medical Sciences, Guilan, Iran","volume":"6","author":"Mansour-Ghanaei","year":"2006","journal-title":"Hepatitis Monthly"},{"key":"10.1016\/j.vaccine.2008.04.054_bib65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0264-410X(90)90132-6","article-title":"Development and persistence of antibody in a high risk institutionalised population given plasma-derived hepatitis B vaccine","volume":"8","author":"West","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib66","first-page":"384","article-title":"Response rate to hepatitis B vaccination in patients with chronic renal failure and end-stage-renal-disease: influence of diabetes mellitus","volume":"10","author":"Taheri","year":"2005","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.vaccine.2008.04.054_bib67","series-title":"Viral Hepatitis 1981 International Symposium","first-page":"451","article-title":"Response to hepatitis B vaccine in a young adult population","author":"Hollinger","year":"1982"},{"key":"10.1016\/j.vaccine.2008.04.054_bib68","doi-asserted-by":"crossref","first-page":"ii1323","DOI":"10.1016\/S0140-6736(83)91089-9","article-title":"Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff: a double-blind placebo-controlled trial","author":"Desmyter","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.054_bib69","doi-asserted-by":"crossref","first-page":"ii1211","DOI":"10.1016\/S0140-6736(80)92477-0","article-title":"Hepatitis B vaccine: immune response in haemodialysis patients","author":"Stevens","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.054_bib70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0163-4453(91)90786-R","article-title":"Immunisation of staff of a regional blood transfusion centre with a recombinant hepatitis B vaccine","volume":"22","author":"Rogan","year":"1991","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2008.04.054_bib71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1017\/S0195941700067266","article-title":"A hepatitis B vaccination program in a community teaching hospital","volume":"8","author":"Tong","year":"1987","journal-title":"Infect Contr"},{"key":"10.1016\/j.vaccine.2008.04.054_bib72","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1016\/j.vaccine.2007.08.025","article-title":"Timing of hepatitis B vaccination: its effect on vaccine response in health care workers","volume":"25","author":"Sabido","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib73","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1016\/S0264-410X(01)00183-9","article-title":"High seroprotection rate induced by low doses of recombinant hepatitis B vaccine in healthy Iranian neonates","volume":"19","author":"Shokri","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s004300050035","article-title":"High rate of seroconversion following administration of a single supplementary dose of recombinant hepatitis B vaccine in Iranian healthy nonresponder neonates","volume":"185","author":"Shokri","year":"1997","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib75","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/tropej\/40.2.104","article-title":"Female children respond to recombinant hepatitis B vaccine with higher titre than male","volume":"40","author":"Fang","year":"1994","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2008.04.054_bib76","doi-asserted-by":"crossref","first-page":"922","DOI":"10.26719\/1999.5.5.922","article-title":"Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children","volume":"5","author":"El-Sawy","year":"1999","journal-title":"Eastern Mediterran Health J"},{"key":"10.1016\/j.vaccine.2008.04.054_bib77","first-page":"281","article-title":"Immune response to hepatitis B vaccine among children in Yemen","volume":"26","author":"Sallam","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1016\/j.vaccine.2008.04.054_bib78","first-page":"98","article-title":"Differential immungenicity of a recombinant hepatitis B vaccine in Iranian Neonates: influence of ethnicity and environmental factors","volume":"1","author":"Jafarzadeh","year":"2004","journal-title":"Iran J Immunol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib79","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1651-2227.2003.tb02477.x","article-title":"Decreased immune response to hepatitis B eight years after routine vaccination in Israel","volume":"92","author":"Gold","year":"2003","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2008.04.054_bib80","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00430-004-0231-4","article-title":"Impact of the expanded program of immunization against hepatitis B injection in school children in Malaysia","volume":"194","author":"Ng","year":"2005","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib81","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1440-1754.2002.00013.x","article-title":"Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants","volume":"38","author":"Cook","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2008.04.054_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2169\/internalmedicine1962.25.25","article-title":"Safety and efficacy of hepatitis B vaccine in hospital personnel","volume":"25","author":"Arakawa","year":"1986","journal-title":"Jpn J Med"},{"key":"10.1016\/j.vaccine.2008.04.054_bib83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-3476(94)70123-7","article-title":"Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four and twelve or fifteen months of age","volume":"125","author":"Keyserling","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2008.04.054_bib84","first-page":"138","article-title":"Immune response to hepatitis B vaccine in health care workers in Hong Kong","volume":"2","author":"Lim","year":"1996","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.vaccine.2008.04.054_bib85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.20006","article-title":"Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination","volume":"39","author":"Chen","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2008.04.054_bib86","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.vaccine.2004.07.024","article-title":"Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil","volume":"23","author":"Brandao","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib87","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/173.2.387","article-title":"Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly","volume":"173","author":"Sankilampi","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib88","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0002-9343(93)90354-R","article-title":"Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaskan native chronic alcoholics compared with non-alcoholic native and non-native controls","volume":"95","author":"McMahon","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2008.04.054_bib89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1651-2227.2003.tb00522.x","article-title":"Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children","volume":"92","author":"Moore","year":"2003","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2008.04.054_bib90","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000070405","article-title":"Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled study","volume":"49","author":"Wagner","year":"2003","journal-title":"Gerontology"},{"key":"10.1016\/j.vaccine.2008.04.054_bib91","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1365-3156.2006.01700.x","article-title":"Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan","volume":"11","author":"Moore","year":"2006","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2008.04.054_bib92","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0264-410X(98)00410-1","article-title":"Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents","volume":"17","author":"Mark","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib93","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s100960000305","article-title":"Effect on diphtheria immunity of combined tetanus and diphtheria booster vaccination in adults","volume":"19","author":"Marlovits","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib94","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s100960050458","article-title":"Booster effect of low doses of tetanus toxoid in elderly vaccines","volume":"19","author":"Bjorkholm","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.04.054_bib95","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1086\/315537","article-title":"Epidemic diphtheria in Belarus, 1992\u20137","volume":"181","author":"Filonov","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib96","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1007558601804","article-title":"Epidemiology of epidemic diphtheria in three regions, Russia 1994\u20131996","volume":"15","author":"Vitek","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib97","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1099\/00222615-48-12-1075","article-title":"Sex differences in antibody-and cell-mediated immune response to rubella re-immunisation","volume":"48","author":"Mitchell","year":"1999","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib98","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1542\/peds.47.1.120","article-title":"A sex difference in immunological responsiveness","volume":"47","author":"Michaels","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.04.054_bib99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1542\/peds.47.1.7","article-title":"Clinical response to immunization with Cendehill strain rubella vaccine","volume":"47","author":"Rogers","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.04.054_bib100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.45.2.110","article-title":"Rubella-associated arthritis 1. Comparative study of joint manifestations associated with natural rubella infection and RA27\/3 rubella immunisation","volume":"45","author":"Tingle","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib101","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(95)92536-8","article-title":"Reduced seroconversion to measles in infants given vitamin A with measles vaccination","volume":"345","author":"Semba","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.054_bib102","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/ije\/23.5.1078","article-title":"Sex differences in the humoral antibody response to live measles vaccine in young adults","volume":"23","author":"Green","year":"1994","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib103","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ije\/25.3.665","article-title":"Child mortality following standard, medium or high titre measles immunization in West Africa","volume":"25","author":"Knudsen","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib104","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.04.054_bib105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4269\/ajtmh.2005.72.339","article-title":"Immunogenicity and safety of Berna-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial","volume":"72","author":"Pfister","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.04.054_bib106","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WH-17D and Brazilian 17DD yellow fever vaccines: a randomised trial","volume":"38","author":"Camacho","year":"2004","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.vaccine.2008.04.054_bib107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/PSY.0b013e318164232e","article-title":"Meningococcal A vaccination response is enhanced by acute stress in men","volume":"70","author":"Edwards","year":"2008","journal-title":"Psychosom Med"},{"key":"10.1016\/j.vaccine.2008.04.054_bib108","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0035-9203(82)90188-2","article-title":"The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria","volume":"76","author":"Mohammed","year":"1982","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.04.054_bib109","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bmj.2.4173.891","article-title":"Tetanus prophylaxis and circulating antitoxin in man and woman","volume":"2","author":"Marvell","year":"1940","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2008.04.054_bib110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/ard.28.2.104","article-title":"Immunological sex differences: a study of patients with rheumatoid arthritis, their relatives and controls","volume":"28","author":"Rhodes","year":"1969","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib111","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib112","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2310\/7060.2002.30088","article-title":"The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic","volume":"9","author":"Lau","year":"2002","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2008.04.054_bib113","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2008.04.054_bib114","first-page":"790","article-title":"The role of vitamin A in enhancing humoral immunity produced by anti rabies vaccine","volume":"7","author":"Siddiqui","year":"2001","journal-title":"Eastern Mediterran Health J"},{"key":"10.1016\/j.vaccine.2008.04.054_bib115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bmj.308.6928.598b","article-title":"Immunity to diphtheria in adults in England","volume":"308","author":"Miller","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2008.04.054_bib116","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0264-410X(00)00176-6","article-title":"Immunity to diphtheria among children in Northern Norway and North-Western Russia","volume":"19","author":"Skogen","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.054_bib117","first-page":"117","article-title":"Prevalence and correlates of diphtheria toxin antibodies among young adults in Israel","volume":"23","author":"Cohen","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.054_bib118","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-3476(97)70313-5","article-title":"T-lymphocyte subsets in West African children: impact of age, sex and season","volume":"130","author":"Lisse","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2008.04.054_bib119","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm1295-1279","article-title":"Genetic control of the CD4\/C8 T cell ratio in humans","volume":"1","author":"Amadori","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2008.04.054_bib120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/cyto.b.10011","article-title":"Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity and smoking","volume":"52B","author":"Uppal","year":"2003","journal-title":"Cytom Part B: Clin Cytom"},{"key":"10.1016\/j.vaccine.2008.04.054_bib121","first-page":"959","article-title":"Peripheral blood lymphocyte subjects in adolescents: a longitudinal analysis from the REACH project","volume":"9","author":"Rudy","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib122","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/eje.0.1430031","article-title":"Consistent production of a higher TH1: TH2 cytokine ratio by stimulated T cells in men compared with women","volume":"143","author":"Giron-Gonzalez","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib123","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1567-5769(01)00044-3","article-title":"Sex hormones as immunomodulation in health and disease","volume":"1","author":"Verthelyi","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0928-8244(03)00202-5","article-title":"Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone","volume":"38","author":"Beagley","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jsbmb.2005.08.010","article-title":"Progesterone and the immunology of pregnancy","volume":"97","author":"Druckmann","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.vaccine.2008.04.054_bib126","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1210\/jc.85.4.1648","article-title":"In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans","volume":"85","author":"Giltay","year":"2000","journal-title":"J Clin Endo Met"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T03:22:35Z","timestamp":1684380155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08005069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":126,"journal-issue":{"issue":"29-30","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0264410X08005069"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}